- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed Marginal Zone Lymphoma in Japan
Total 80 results
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Calithera Biosciences, IncTerminatedLymphoma, Non-Hodgkin | Lymphoma, Follicular, Marginal ZoneKorea, Republic of, Japan
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
TakedaCompletedGastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and OtherJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Eisai Co., Ltd.CompletedGastric Low-grade MALT Lymphoma With Helicobacter Pylori PositiveJapan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaJapan
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Eisai Inc.CompletedLymphoma, T-cell, Peripheral | Lymphoma, T-cell, CutaneousJapan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Osaka City UniversityCompleted
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
Daiichi SankyoActive, not recruitingRelapsed/Refractory Peripheral T-Cell Lymphoma | Adult T Cell Leukemia/LymphomaUnited States, Spain, Japan, United Kingdom, Korea, Republic of, France, Italy, Australia, Canada, Germany, Netherlands, Taiwan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Astellas Pharma IncOno Pharmaceutical Co. LtdCompletedOsteoporosis | Bone Loss, Age-RelatedJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Toshihiko KonoUnknown
-
AstraZenecaActive, not recruitingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)Japan
-
Novo Nordisk A/SCompletedFoetal Growth Problem | Small for Gestational AgeJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyJapan
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedAchondroplasia | Genetic DisorderJapan
-
PfizerCompletedMenopause | Vaginitis | Metrorrhagia | Primary Ovarian InsufficiencyJapan
-
Novo Nordisk A/SRecruitingGrowth Hormone Deficiency in ChildrenJapan
-
Versartis Inc.TerminatedGrowth Disorders | Pediatric Growth Hormone DeficiencyJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
AmgenAmgen Astellas Biopharma K.K.CompletedRelapsed Refractory B Precursor Acute Lymphoblastic LeukemiaJapan
-
Kyowa Kirin Co., Ltd.CompletedEnd Stage Renal Disease | Hyperparathyroidism, SecondaryJapan
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Follicular LymphomaUnited States, Korea, Republic of, Taiwan, China, Spain, United Kingdom, Australia, France, Germany, Japan, Turkey, Brazil, Poland, Ukraine, Italy, Russian Federation
-
CelgeneRecruiting
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Novo Nordisk A/SCompletedTurner Syndrome | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Genetic DisorderJapan
-
Novo Nordisk A/SEnrolling by invitationAdult Growth Hormone DeficiencyJapan
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Japan